292 related articles for article (PubMed ID: 1871107)
1. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.
Burley SK; David PR; Lipscomb WN
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):6916-20. PubMed ID: 1871107
[TBL] [Abstract][Full Text] [Related]
2. Structure determination and refinement of bovine lens leucine aminopeptidase and its complex with bestatin.
Burley SK; David PR; Sweet RM; Taylor A; Lipscomb WN
J Mol Biol; 1992 Mar; 224(1):113-40. PubMed ID: 1548695
[TBL] [Abstract][Full Text] [Related]
3. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase.
Taylor A; Peltier CZ; Jahngen EG; Laxman E; Szewczuk Z; Torre FJ
Biochemistry; 1992 Apr; 31(16):4141-50. PubMed ID: 1567860
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
Taylor A; Peltier CZ; Torre FJ; Hakamian N
Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382
[TBL] [Abstract][Full Text] [Related]
5. Re-refinement of the X-ray crystal structure of bovine lens leucine aminopeptidase complexed with bestatin.
Kim H; Burley SK; Lipscomb WN
J Mol Biol; 1993 Apr; 230(3):722-4. PubMed ID: 8478928
[TBL] [Abstract][Full Text] [Related]
6. Transition state analogue L-leucinephosphonic acid bound to bovine lens leucine aminopeptidase: X-ray structure at 1.65 A resolution in a new crystal form.
Sträter N; Lipscomb WN
Biochemistry; 1995 Jul; 34(28):9200-10. PubMed ID: 7619821
[TBL] [Abstract][Full Text] [Related]
7. X-ray crystallographic determination of the structure of bovine lens leucine aminopeptidase complexed with amastatin: formulation of a catalytic mechanism featuring a gem-diolate transition state.
Kim H; Lipscomb WN
Biochemistry; 1993 Aug; 32(33):8465-78. PubMed ID: 8357796
[TBL] [Abstract][Full Text] [Related]
8. The slow, tight binding of bestatin and amastatin to aminopeptidases.
Wilkes SH; Prescott JM
J Biol Chem; 1985 Oct; 260(24):13154-62. PubMed ID: 2865258
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic and X-ray crystallographic characterization of bestatin bound to the aminopeptidase from Aeromonas (Vibrio) proteolytica.
Stamper CC; Bienvenue DL; Bennett B; Ringe D; Petsko GA; Holz RC
Biochemistry; 2004 Aug; 43(30):9620-8. PubMed ID: 15274616
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization and structural prediction of a novel cytosolic leucyl aminopeptidase of the M17 family from Schizosaccharomyces pombe.
Herrera-Camacho I; Rosas-Murrieta NH; Rojo-Domínguez A; Millán L; Reyes-Leyva J; Santos-López G; Suárez-Rendueles P
FEBS J; 2007 Dec; 274(23):6228-40. PubMed ID: 18028193
[TBL] [Abstract][Full Text] [Related]
11. Molecular structure of leucine aminopeptidase at 2.7-A resolution.
Burley SK; David PR; Taylor A; Lipscomb WN
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6878-82. PubMed ID: 2395881
[TBL] [Abstract][Full Text] [Related]
12. Two-metal ion mechanism of bovine lens leucine aminopeptidase: active site solvent structure and binding mode of L-leucinal, a gem-diolate transition state analogue, by X-ray crystallography.
Sträter N; Lipscomb WN
Biochemistry; 1995 Nov; 34(45):14792-800. PubMed ID: 7578088
[TBL] [Abstract][Full Text] [Related]
13. Differentiation and identification of the two catalytic metal binding sites in bovine lens leucine aminopeptidase by x-ray crystallography.
Kim H; Lipscomb WN
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5006-10. PubMed ID: 8506345
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the leucine aminopeptidase from Pseudomonas putida reveals the molecular basis for its enantioselectivity and broad substrate specificity.
Kale A; Pijning T; Sonke T; Dijkstra BW; Thunnissen AM
J Mol Biol; 2010 May; 398(5):703-14. PubMed ID: 20359484
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes.
Rich DH; Moon BJ; Harbeson S
J Med Chem; 1984 Apr; 27(4):417-22. PubMed ID: 6142952
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin.
Nankya-Kitaka MF; Curley GP; Gavigan CS; Bell A; Dalton JP
Parasitol Res; 1998 Jul; 84(7):552-8. PubMed ID: 9694371
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic implications of the inhibition of peptidases by amino aldehydes and bestatin.
Frick L; Wolfenden R
Biochim Biophys Acta; 1985 Jul; 829(3):311-8. PubMed ID: 3890953
[TBL] [Abstract][Full Text] [Related]
19. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Grembecka J; Mucha A; Cierpicki T; Kafarski P
J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cleavage of diaminopimelate-containing isopeptides by leucine aminopeptidase and matrix metalloproteinases in tumors: application to bioadhesive peptides.
Yamazaki Y; Savva M; Kleinman HK; Oka S; Mokotoff M
J Pept Res; 1999 Feb; 53(2):177-87. PubMed ID: 10195455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
